Your browser doesn't support javascript.
loading
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF COVID-19 PATIENTS IN KENYA
Loice Achieng Ombajo; Nyamai Mutono; Paul Sudi; Mbuvi Mutua; Mohammed Sood; Alliyy Muhammad Loo; Phoebe Juma; Jackline Odhiambo; Reena Shah; Frederick Wangai; Marybeth Maritim; Omu Anzala; Patrick Amoth; Evans Kamuri; Waweru Munyu; Sam Mwangi Thumbi.
Affiliation
  • Loice Achieng Ombajo; University of Nairobi
  • Nyamai Mutono; Washington State University
  • Paul Sudi; Kenyatta National Hospital
  • Mbuvi Mutua; Kenyatta National Hospital
  • Mohammed Sood; Coast General Teaching and Referral Hospital
  • Alliyy Muhammad Loo; Coast General Teaching and Referral Hospital
  • Phoebe Juma; University of Nairobi
  • Jackline Odhiambo; The Nairobi Hospital
  • Reena Shah; AgaKhan University Hospital
  • Frederick Wangai; University of Nairobi
  • Marybeth Maritim; University of Nairobi
  • Omu Anzala; Kenya-AIDS Vaccine Initiative/Institute of Clinical Research
  • Patrick Amoth; Ministry of Health, Kenya
  • Evans Kamuri; Kenyatta National Hospital
  • Waweru Munyu; Avenue Healthcare
  • Sam Mwangi Thumbi; Washington State University, Paul G Allen School for Global Animal Health
Preprint in English | medRxiv | ID: ppmedrxiv-20228106
ABSTRACT
BackgroundMore than 49,000 cases of infection and 900 deaths from COVID-19 have been recorded in the Kenya. However, the characteristics and risk factors for severe outcomes among hospitalized COVID-19 patients in this setting have not been described. MethodsWe extracted demographic, laboratory, clinical and outcome data from medical records of RT-PCR confirmed SARS-CoV2 patients admitted in six hospitals in Kenya between March and September, 2020. We used Cox proportional hazards regressions to determine factors related to in-hospital mortality. ResultsData from 787 COVID-19 patients was available. The median age was 43 years (IQR 30-53), with 505 (64%) males. At admission, 455 (58%) were symptomatic. The commonest symptoms were cough (337, 43%), loss of taste or smell (279, 35%), and fever (126, 16%). Co-morbidities were reported in 340 (43%), with cardiovascular disease, diabetes and HIV documented in 130 (17%), 116 (15%), 53 (7%) respectively. 90 (11%) were admitted to ICU for a mean of 11 days, 52 (7%) were ventilated with a mean of 10 days, 107 (14%) died. The risk of death increased with age [hazard ratio (HR) 1.57 (95% CI 1.13 - 2.19)] for persons >60 years compared to those <60 years old; having co-morbidities [HR 2.34 (1.68 - 3.25)]; and among males [HR 1.76 (1.27, 2.44)] compared to females. Elevated white blood cell count and aspartate aminotransferase were associated with higher risk of death. ConclusionsWe identify the risk factors for mortality that may guide stratification of high risk patients.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study Language: English Year: 2020 Document type: Preprint
...